Ajanta Pharma (AJANTPHARM) — Announcement

Ajanta Pharma released the written transcript of its Q4 earnings call held on May 5, 2026, confirming the call took place at 4:30 p.m. and is now available on its investor website for record purposes.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AJANTPHARM ✨ Ask AI About This

About Ajanta Pharma Limited (AJANTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹39,694.55 Cr P/E: 37.6 ROE: 23.3% ROCE: 29.4%

View full AJANTPHARM stock details →

📡 Get AI alerts when AJANTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AJANTPHARM — Free

💡 Ask AI about this filing

"How does this announcement affect Ajanta Pharma Limited's outlook?" "What did Ajanta Pharma Limited announce on 8 May 2026?" "Is this positive or negative for AJANTPHARM?"

Ask AI Free →

📊 More AJANTPHARM filings

See all AJANTPHARM filings →

🔥 Also filed on 8 May 2026

RPGLIFE RPG Life Sciences Limited Financial Results RBA Restaurant Brands Asia Limited Financial Results RAIN Rain Industries Limited Financial Results ROUTE ROUTE MOBILE LIMITED Offer Document ROUTE ROUTE MOBILE LIMITED Financial Results RUSTOMJEE Keystone Realtors Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AJANTPHARM files new disclosures

Track AJANTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.